Session

Upper GI endoscopy and neoplasia (Posters)

LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY
LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY

Upper GI endoscopy and neoplasia (Posters)  et al.

ESOPHAGEAL CANCERS MISSED AT UPPER ENDOSCOPY IN CENTRAL NORWAY 2004 TO 2021 – A POPULATION BASED STUDY
ESOPHAGEAL CANCERS MISSED AT UPPER ENDOSCOPY IN CENTRAL NORWAY 2004 TO 2021 – A POPULATION BASED STUDY

Upper GI endoscopy and neoplasia (Posters)  et al.

MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES
MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES

Upper GI endoscopy and neoplasia (Posters)  et al.

ARTIFICIAL INTELLIGENCE-ASSISTED ENDOSCOPY FOR GASTRIC CANCER SCREENING IN CHINA: A COST EFFECTIVENESS ANALYSIS
ARTIFICIAL INTELLIGENCE-ASSISTED ENDOSCOPY FOR GASTRIC CANCER SCREENING IN CHINA: A COST EFFECTIVENESS ANALYSIS

Upper GI endoscopy and neoplasia (Posters)  et al.

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Upper GI endoscopy and neoplasia (Posters)  et al.

INCREASED RISK OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH SQUAMOUS DYSPLASIA: A NATIONWIDE COHORT STUDY IN THE NETHERLANDS
INCREASED RISK OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH SQUAMOUS DYSPLASIA: A NATIONWIDE COHORT STUDY IN THE NETHERLANDS

Upper GI endoscopy and neoplasia (Posters)  et al.

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY PARAMETERS ASSOCIATED WITH HISTOLOGICAL OUTCOMES IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA
18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY PARAMETERS ASSOCIATED WITH HISTOLOGICAL OUTCOMES IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Upper GI endoscopy and neoplasia (Posters)  et al.

SALVAGE ENDOSCOPIC THERAPY FOR CT1N0M0 LOCAL FAILURE AFTER CHEMORADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MULTICENTER RETROSPECTIVE STUDY
SALVAGE ENDOSCOPIC THERAPY FOR CT1N0M0 LOCAL FAILURE AFTER CHEMORADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MULTICENTER RETROSPECTIVE STUDY

Upper GI endoscopy and neoplasia (Posters)  et al.

HUMAN-MACHINE INTERACTION IN DETECTION OF BARRETT’S NEOPLASIA USING A NOVEL DEEP NEURAL NETWORK IN THE EVOLVING ERA OF ARTIFICIAL INTELLIGENCE
HUMAN-MACHINE INTERACTION IN DETECTION OF BARRETT’S NEOPLASIA USING A NOVEL DEEP NEURAL NETWORK IN THE EVOLVING ERA OF ARTIFICIAL INTELLIGENCE

Upper GI endoscopy and neoplasia (Posters)  et al.

ENDOSCOPIC SURVEILLANCE IN AN EXPERT BARRETT’S CENTRE ASSOCIATES WITH HIGH DETECTION OF EARLY NEOPLASIA AND LOW DISEASE-SPECIFIC MORTALITY
ENDOSCOPIC SURVEILLANCE IN AN EXPERT BARRETT’S CENTRE ASSOCIATES WITH HIGH DETECTION OF EARLY NEOPLASIA AND LOW DISEASE-SPECIFIC MORTALITY

Upper GI endoscopy and neoplasia (Posters)  et al.

HUMAN-MACHINE INTERACTION IN DETECTION OF BARRETT’S NEOPLASIA USING A NOVEL DEEP NEURAL NETWORK IN THE EVOLVING ERA OF ARTIFICIAL INTELLIGENCE
HUMAN-MACHINE INTERACTION IN DETECTION OF BARRETT’S NEOPLASIA USING A NOVEL DEEP NEURAL NETWORK IN THE EVOLVING ERA OF ARTIFICIAL INTELLIGENCE

ENDOSCOPIC SURVEILLANCE IN AN EXPERT BARRETT’S CENTRE ASSOCIATES WITH HIGH DETECTION OF EARLY NEOPLASIA AND LOW DISEASE-SPECIFIC MORTALITY
ENDOSCOPIC SURVEILLANCE IN AN EXPERT BARRETT’S CENTRE ASSOCIATES WITH HIGH DETECTION OF EARLY NEOPLASIA AND LOW DISEASE-SPECIFIC MORTALITY

LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY
LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY

SALVAGE ENDOSCOPIC THERAPY FOR CT1N0M0 LOCAL FAILURE AFTER CHEMORADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MULTICENTER RETROSPECTIVE STUDY
SALVAGE ENDOSCOPIC THERAPY FOR CT1N0M0 LOCAL FAILURE AFTER CHEMORADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MULTICENTER RETROSPECTIVE STUDY

ESOPHAGEAL CANCERS MISSED AT UPPER ENDOSCOPY IN CENTRAL NORWAY 2004 TO 2021 – A POPULATION BASED STUDY
ESOPHAGEAL CANCERS MISSED AT UPPER ENDOSCOPY IN CENTRAL NORWAY 2004 TO 2021 – A POPULATION BASED STUDY

MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES
MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES

ARTIFICIAL INTELLIGENCE-ASSISTED ENDOSCOPY FOR GASTRIC CANCER SCREENING IN CHINA: A COST EFFECTIVENESS ANALYSIS
ARTIFICIAL INTELLIGENCE-ASSISTED ENDOSCOPY FOR GASTRIC CANCER SCREENING IN CHINA: A COST EFFECTIVENESS ANALYSIS

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

INCREASED RISK OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH SQUAMOUS DYSPLASIA: A NATIONWIDE COHORT STUDY IN THE NETHERLANDS
INCREASED RISK OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH SQUAMOUS DYSPLASIA: A NATIONWIDE COHORT STUDY IN THE NETHERLANDS

18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY PARAMETERS ASSOCIATED WITH HISTOLOGICAL OUTCOMES IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA
18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY PARAMETERS ASSOCIATED WITH HISTOLOGICAL OUTCOMES IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Item 1 - 20 / 20
1